Artesunate Sensitizes Human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy

In conclusion, artesunate may be a promising strategy to mitigate sorafenib resistance in HCC via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy.PMID:37733919 | DOI:10.1080/15548627.2023.2261758

Source: Autophagy - September 21, 2023 Category: Cytology Authors: Zhaochen Ma Wenjia Chen Yudong Liu Lingxiang Yu Xia Mao Xiaodong Guo Funeng Jiang Qiuyan Guo Na Lin Yanqiong Zhang Source Type: research